Mirago S 25 Tablet ER: A Combined Approach to Urinary Incontinence

Mirago S 25 Tablet ER is a controlled release formulation of Mirabegron (25mg) combined with Solifenacin (5mg). This unique combination targets both urgency and overactive bladder symptoms, effectively relieving urinary incontinence.

Mirabegron acts as a beta-3 adrenergic agonist, relaxing the bladder muscles to increase urine flow and reduce the sensation of urgency. Meanwhile, Solifenacin is a muscarinic receptor antagonist that relaxes the smooth muscle in the bladder neck, inhibiting its contraction and allowing for easier urination. This synergistic effect minimizes both urgency and frequency issues often associated with urinary incontinence.

Mirago S 25 Tablet ER offers prolonged relief for up to 12 hours. By providing continuous action over time, it supports a more comfortable and reliable daily routine. This medication is designed to be taken once per day as prescribed by your physician, ensuring consistent effectiveness throughout the treatment duration.

Note: This information is intended for general knowledge only and does not substitute professional medical advice. Always consult with a healthcare professional before starting or altering any treatment regimen.